Subject Information Sample Clauses

Subject Information. All Clinical Trial Information will be furnished to Company or a representative of Company without patient names. Company and its designee has the right to review patient records and other relevant raw data to verify entries in the CRFs. Company shall not at any time disclose the name of any Subject or any information which identifies a Subject to a third party unless specifically required to do so by Applicable Law or the FDA.
AutoNDA by SimpleDocs
Subject Information. All Clinical Trial Information will be furnished to Sponsor or a representative of Sponsor without Subject names. Sponsor and its designee has the right to review Subject records and other relevant raw data to verify entries in the CRFs. Sponsor shall not at any time disclose the name of any Subject or any information which identifies a Subject to a third party unless specifically required to do so by Applicable Law or the FDA.
Subject Information. Quantum acknowledges that (i) PTI currently may have, and later may come into possession of, information with respect to the Subject PTI Common Stock and AMSC that is not known to Quantum and that may be material to a decision of Quantum (the “Subject Information”), (ii) Quantum has determined to enter into this transaction notwithstanding Quantum’s lack of knowledge of Subject Information and (iii) PTI shall have no liability to Quantum, and Quantum waives and releases any claims that it might have against PTI whether under applicable securities laws or otherwise, with respect to the nondisclosure of Subject Information in connection with this transaction; provided, however, that Subject Information and does not affect the truth or accuracy of PTI’s representations and warranties in this Agreement.
Subject Information. Gender Age Weight Height
Subject Information. If DCR, Institution, Investigator, Sponsor or Sponsor's Designee (as defined below) shall come into contact with any Study Subject's medical records, each of them shall hold in confidence the identity of such Subject and shall comply with all applicable law(s) regarding the confidentiality of such subject's records. To the extent that DCR, the Investigators, or any other person or entity involved in the Study (other than as a subject) is a "covered entity" under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), DCR warrants that DCR will cause Investigators to obtain a valid HIPAA Privacy Rule authorization, as prescribed in 45 C.F.R. §164.508(b) from each individual participating in the Study permitting disclosures from DCR and/or the Investigators to Sponsor and any and all other clinical trial service providers of the individual's "protected health information" (as defined in HIPAA) as required by and in accordance with the Study, which such authorization will permit Sponsor's use [and disclosure] of such protected health information for the purposes of monitoring the accuracy and completeness of the research data, performing clinical and scientific research, and medical product development.
Subject Information. Each Party shall be provided with subject information as allowed by law and the subject consent and authorization documents and shall maintain the confidentiality of all such subject information, unless specifically required to disclose such information by law.
Subject Information. UCHC and Licensee shall keep any technology, formula, trade secrets, technical data or business information ("Information") provided or made available by or otherwise obtained from the other Party or its Affiliates hereunder confidential. Neither UCHC nor Licensee shall, without the prior written consent of the other Party or its Affiliates, as the case may be, use (except as expressly permitted by this Agreement), or disclose to any third party, any Information provided or made available by the other Party or its Affiliates hereunder; provided, however, that the foregoing shall not apply to information which the Party receiving such information can establish by written documentation to: (a) have been publicly known at the time of disclosure by the other Party or its Affiliates, as the case may be, (b) have become publicly known, without fault on its part, subsequent to such disclosure, (c) have been otherwise obtained without restriction from a source (other than the other Party or its agents or Affiliates), lawfully having the right to disclose such information, or (d) have been developed by it or its Affiliates independently without use of or reference to the Information as disclosed hereunder by the other Party or its Affiliates.
AutoNDA by SimpleDocs
Subject Information. If you are requesting driving record information, the subject will be the person you are requesting information on. If you are requesting vehicle information, the subject will be the vehicle owner (if available). SUBJECT FULL NAME (last, first, mi, suffix) CHECK TO INDICATE SUBJECT NAME AND ADDRESS IS THE SAME AS THE REQUESTER ABOVE. STREET ADDRESS CITY STATE ZIP CODE Check one or more boxes below to indicate the type of information you wish to receive. All data fields must be completed for Driving Record Information, Vehicle Information and Decedent Photo Requests. For Police Crash Reports provide as much information as possible. DRIVING RECORD INFORMATION (Includes license history and conviction data) (complete SUBJECT INFORMATION above) SUBJECT DRIVER LICENSE NUMBER or SUBJECT BIRTH DATE (mm/dd/yyyy) REASON FOR REQUEST (Check one) Insurance Employment, School, or Military Member/Applicant/Volunteer Personal Use, Court, or Attorney TNC An authorization from the subject is required for employers and others not authorized by Virginia code. I authorize the Department of Motor Vehicles to furnish, for this one time only, information pertaining to my driving record to the requester identified above. SUBJECT SIGNATURE DATE (mm/dd/yyyy) VEHICLE INFORMATION (Includes vehicle description and registration data) (complete SUBJECT INFORMATION above) VEHICLE IDENTIFICATION NUMBER (VIN) VEHICLE MAKE VEHICLE YEAR POLICE CRASH REPORT IMPORTANT NOTE: The Department may only release a full crash report in accordance with VA Code § 46.2-380. Check one or more boxes to indicate your involvement in the crash: I was a DRIVER. I was a PASSENGER. I legally REPRESENT a person injured or involved in the crash. I was injured in the crash or as a result thereof (ex: injured pedestrian). I am the parent or legal guardian of a minor injured or killed in the crash. I am the owner of a vehicle/property involved in the crash. I am the personal representative (guardian, executor, next of kin, etc.) of a person injured or killed in the crash. I am an authorized representative of any insurance carrier reasonably anticipating exposure to civil liability as a consequence of the crash or to which a person has applied for issuance or renewal of a policy of automobile insurance. INFORMATION REQUESTED (continued) CRASH DATE (mm/dd/yyyy) TIME OF CRASH CRASH LOCATION (highway or street name) CITY/COUNTY/TOWN WHERE CRASH OCCURRED DRIVER FULL NAME (last, first, mi, suffix) DRIVER LICENSE NUMBER

Related to Subject Information

  • Project Information Except for confidential information designated by the City as information not to be shared, Consultant agrees to share Project information with, and to fully cooperate with, those corporations, firms, contractors, public utilities, governmental entities, and persons involved in or associated with the Project. No information, news, or press releases related to the Project, whether made to representatives of newspapers, magazines, or television and radio stations, shall be made without the written authorization of the City’s Project Manager.

  • CONTRACT INFORMATION 1. The State of Arkansas may not contract with another party: a. Upon default, to pay all sums to become due under a contract. b. To pay damages, legal expenses or other costs and expenses of any party. c. To conduct litigation in a place other than Pulaski County, Arkansas d. To agree to any provision of a contract; which violates the laws or constitution of the State of Arkansas. 2. A party wishing to contract with the State of Arkansas should: a. Remove any language from its contract which grants to it any remedies other than: i. The right to possession. ii. The right to accrued payments. iii. The right to expenses of de-installation. iv. The right to expenses of repair to return the equipment to normal working order, normal wear and tear excluded. v. The right to recover only amounts due at the time of repossession and any unamortized nonrecurring cost as allowed by Arkansas Law. b. Include in its contract that the laws of the State of Arkansas govern the contract. c. Acknowledge that contracts become effective when awarded by the State Procurement Official.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Confidential System Information HHSC prohibits the unauthorized disclosure of Other Confidential Information. Grantee and all Grantee Agents will not disclose or use any Other Confidential Information in any manner except as is necessary for the Project or the proper discharge of obligations and securing of rights under the Contract. Grantee will have a system in effect to protect Other Confidential Information. Any disclosure or transfer of Other Confidential Information by Xxxxxxx, including information requested to do so by HHSC, will be in accordance with the Contract. If Grantee receives a request for Other Confidential Information, Xxxxxxx will immediately notify HHSC of the request, and will make reasonable efforts to protect the Other Confidential Information from disclosure until further instructed by the HHSC. Grantee will notify HHSC promptly of any unauthorized possession, use, knowledge, or attempt thereof, of any Other Confidential Information by any person or entity that may become known to Grantee. Grantee will furnish to HHSC all known details of the unauthorized possession, use, or knowledge, or attempt thereof, and use reasonable efforts to assist HHSC in investigating or preventing the reoccurrence of any unauthorized possession, use, or knowledge, or attempt thereof, of Other Confidential Information. HHSC will have the right to recover from Grantee all damages and liabilities caused by or arising from Grantee or Grantee Agents’ failure to protect HHSC’s Confidential Information as required by this section.

  • KYC Information (i) Upon the reasonable request of the Lender made at least 1 day prior to the Closing Date, the Borrower shall have provided to the Lender the documentation and other information so requested in connection with applicable “know your customer” and anti-money-laundering rules and regulations, including the PATRIOT Act, in each case at least five days prior to the Closing Date. (ii) [reserved].

  • Trade Secrets and Confidential Information/Company Property Employee reaffirms and agrees to observe and abide by the terms of the Employment Agreement and the Confidentiality Agreement, specifically including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information, and the restrictive covenants contained therein. Employee’s signature below constitutes his certification under penalty of perjury that he has returned all documents and other items provided to Employee by the Company, developed or obtained by Employee in connection with his employment with the Company, or otherwise belonging to the Company.

  • Information The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company. Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below. The Buyer understands that its investment in the Securities involves a significant degree of risk. The Buyer is not aware of any facts that may constitute a breach of any of the Company's representations and warranties made herein.

  • - CLEC INFORMATION 3.1 Except as otherwise required by law, CenturyLink will not provide or establish Interconnection, Unbundled Network Elements, ancillary services and/or resale of Telecommunications Services in accordance with the terms and conditions of this Agreement prior to CLEC's execution of this Agreement. The Parties shall complete CenturyLink's "New Customer Questionnaire," as it applies to CLEC's obtaining of Interconnection, Unbundled Network Elements, ancillary services, and/or resale of Telecommunications Services hereunder. 3.2 Prior to placing any orders for services under this Agreement, the Parties will jointly complete the following sections of CenturyLink's "New Customer Questionnaire:" General Information Billing and Collection (Section 1) Credit Information Billing Information Summary Billing OSS and Network Outage Notification Contact Information System Administration Contact Information Ordering Information for LIS Trunks, Collocation, and Associated Products (if CLEC plans to order these services) Design Layout Request – LIS Trunking and Unbundled Loop (if CLEC plans to order these services) 3.2.1 The remainder of this questionnaire must be completed within two (2) weeks of completing the initial portion of the questionnaire. This questionnaire will be used to: Determine geographical requirements; Identify CLEC identification codes; Determine CenturyLink system requirements to support CLEC's specific activity; Collect credit information; Obtain Billing information; Create summary bills; Establish input and output requirements; Create and distribute CenturyLink and CLEC contact lists; and Identify CLEC hours and holidays. 3.2.2 CLECs that have previously completed a Questionnaire need not fill out a New Customer Questionnaire; however, CLEC will update its New Customer Questionnaire with any changes in the required information that have occurred and communicate those changes to CenturyLink. Before placing an order for a new product, CLEC will need to complete the relevant New Product Questionnaire and amend this Agreement.

  • Trade Secrets and Confidential Information (i) Executive represents and warrants that Executive (A) is not subject to any legal or contractual duty or agreement that would prevent or prohibit Executive from performing the duties contemplated by this Agreement or otherwise complying with this Agreement, and (B) is not in breach of any legal or contractual duty or agreement, including any agreement concerning trade secrets or confidential information owned by any other party. (ii) Executive agrees that Executive will not (A) use, disclose or reverse engineer Trade Secrets or Confidential Information for any purpose other than the Company’s Business, except as authorized in writing by the Company; (B) during Executive’s employment with the Company, use, disclose or reverse engineer (1) any confidential information or trade secrets of any former employer or third party or (2) any works of authorship developed in whole or in part by Executive during any former employment or for any other party, unless authorized in writing by the former employer or third party; or (C) upon Executive’s resignation or termination with the Company (1) retain Trade Secrets or Confidential Information, including any copies existing in any form (including electronic form), which are in Executive’s possession or control or (2) destroy, delete or alter Trade Secrets or Confidential Information without the Company’s prior written consent. (iii) The obligations under this Section 8 shall remain in effect as long as Trade Secrets and Confidential Information constitute trade secrets or confidential information under applicable law. The confidentiality, property and proprietary rights protections available in this Agreement are in addition to, and not exclusive of, any and all other rights to which the Company is entitled under federal and state law, including, but not limited to, rights provided under copyright laws, trade secret and confidential information laws and laws concerning fiduciary duties.

  • Exclusions from Confidential Information Receiving Party's obligations under this Agreement do not extend to information that is: (a) publicly known at the time of disclosure or subsequently becomes publicly known through no fault of the Receiving Party; (b) discovered or created by the Receiving Party before disclosure by Disclosing Party; (c) learned by the Receiving Party through legitimate means other than from the Disclosing Party or Disclosing Party's representatives; or (d) is disclosed by Receiving Party with Disclosing Party's prior written approval.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!